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ABSTRACT 
In order to investigate the relationship between cancer incidence and hypertension， a 
retrospective cohort stucly had been performed in Tottori Prefecture in J apan. The subjects 
were chosen among people who received health examination in each community from Janu-
ary 1992 to .December 1998. The initial received health examination was set as the start 
point of the observation period. We selected a total of 30， 148 peoples of over 40 years of 
age without cancer within 2 years of the initial health examination. Cancer incidence was 
identified by record linkage with the cancer registry in Tottori prefecture. Total observa-
tion years were 139，231 person years. Cox proportional hazard regression models were used 
to test a relationship between cancer incidence and hypertension after adjustment for sex， 
age， smoking status， body mass index， and alcohol consumption. In this study period， 190 
men and 175 females had been diagnosed cancer. Men who had border1ine hypertension 
had a hazard ratio (HR) of 1. 04 (95 % IC 0.65-1. 68) that was higher than normal. Men 
with untreated hypertension had HR of 0.98 (95 % IC 0.57-1. 68)， while men with treated 
hypertension had HR of 0.63 (95 % IC 0.28-1. 41). Females who had border1ine hyperten-
sion had HR of 1.1 (95 % IC 0.69-1.78). Females with untreated hypertension had HR 
of 1. 32 (95 % IC 0.78-2.21)， and females with treated hypertension had HR of 1. 01 (95 
% IC 0.44-2.36). These HR were not statistically significant. These results suggested that 
there were no significant relationship between cancer incidence and hypertension in this co-
hort. 、 (Acceptedon May 31， 2004) 
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正常血圧群 境界域群 非治療の高血圧群 治療中の高血圧群
男性 総数 6，031(59.0) 2，026 (19.8) 862( 8.4) 1， 311 (12. 8) 
40-49歳 1， 193 (81. 5) 163(11.1) 77(5.3) 31( 2.1) 
50-59歳 1， 254(65. 8) 334(17.5) 159( 8.3) 160( 8.4) 
60-69歳 2;749(53.6) 1， 126(21.9) 482( 9.4) 775 (15.1) 
70歳以上 835(48.3) 403 (23.3) 144 ( 8.3) 345(20.0) 
女性 総数 12，542(63.0) 3，490(17.5) 970(4.9) 2，916(14.6) 
40-49歳 2，681(87.0) 245( 7.9) 68( 2.2) 88( 2.9) 
50-59歳 3， 788 (71. 0) 826(15.5) 218(4.1) 500( 9.4) 
60-69歳 4，767(55.7) L 778 (20.8) 502( 5.9) 1， 509(17. 6) 




非喫煙 喫煙 過去喫煙 3合未満/日 3合以上/日
男性 3，022(34.0) 3，701 (41. 6) 2， 165 (24.4) 9， 705( 94.9) 525(5.1) 
女性 17，523(98.5) 209 ( 1.2) 58( 0.3) 19，909(100.0) 9 (0.0) 
総数 20，545(77.0) 3，910(14.7) 2，223(8.3) 29，614(98.2) 534(1.8) 
)内の数値は%


















全体 190 421. 1 175 185.9 
40-49歳 9 148.2 10 74.7 
50-59歳 27 308.8 51 197.7 
60-69歳 126 548.1 84 201. 5 









ハザード比 95%信頼区間 有意確率 ハザード比 95%信頼区間 有意確率
血圧分類
正常血圧 1. 00 1. 00 
境界域 1. 04 0.65-1.68 0.873 1.1 0.69-1. 78 0.659 
非治療の高血庄 0.98 0.57-1.68 0.936 1. 32 0.78-2.21 0.300 
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